Breaking #AI #Health #Stock News: GBT (OTC: $GTCH) Launches Large Scale Testing For Its qTerm GEN II Prototype;
#ArtificialIntelligence
This Larger Scale Testing Aims
To Collect Expanded Data From General Population And To Be Used For Potential #FDA
Certification Process
SAN DIEGO, CA - July 15, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTC PINK: GTCH) ("GBT”, or the “Company”) is launching a larger scale testing for its qTerm GEN II prototype device. GEN II release is a second release that includes series of enhancements for higher accuracy, consistency and compatibility with a broader spectrum of user’s usage and behavior.
Read this news, featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/07151qTerm-GEN-II-Prototype.asp
GBT's qTerm, a human vitals intelligence
device is aimed to measure human vitals with a touch of a finger. Initial
results of qTerm’s GEN II prototype are successful and the company is launching
phase II testing for a larger group of users. In this testing we will test the
device on a vast age group of volunteers. Additionally, we plan to perform
testing in different geographical locations and their surrounding environments.
The data will be recorded and analyzed to conclude the device’s; software,
analytics and mobile application. The qTerm
device measures body temperature, blood oxygen and heart rate – vitals and the next
release plans possibly to include blood pressure.
The device includes sensors for
oxygen (SPO2), heart rate and IR (Infra-Red) type for temperature. A coprocessor
chip provides an advanced adjusting algorithm to support broader user’s measuring
habits, while compensating for different inputs. The device is accompanied by a
smartphone app and synchronized web application to keep a history and provide
analytics. This larger scale testing phase data is targeted to also to be used
for the FDA certification process, certification which there is no guaranty the
Company will be able to obtain.
"We are expanding our
qTerm’s testing scale as phase I testing produced very successful results.
qTerm GEN II has proven to offer better compatibility for the general
population with accurate result’s and overall reliability. Phase II testing
will include a larger number of users within wider age group, diverse health
conditions, lifestyle and occupation. We are interested to learn more about how,
where and when people will be using the device, throughout their daily lives. We
will evaluate qTerm prototype for user’s measurement habits and record the data
for further analysis. GEN II version improvements significantly increase the
device’s overall performance, accuracy and consistency. We target the larger
scale testing to be used as part of the potential FDA certification process. qTerm’s
device is planned for personal and telemedicine usages. Based on the larger
scale data we expect to fine tune the device’s software and mobile application.
The device is planned to include an Artificial Intelligence technology that will
be offering personal calibration, real-time health statistics and monitoring. One
of the major aspects for our larger testing group is to get more data about the
devices ease of use and user friendliness aspects. The larger scale testing is
planned to take about 30 days, which shortly after, we plan to start creating a
commercial version to be handed in. We have a wide variety of potential
business partners and customers for qTerm and believe that it can be an
efficient health monitoring device. As part of our thorough quality assurance
processes we are on a constant mission to ensure the device’s highest performance,
bringing it to the highest standards and industry’s regulations," said
Danny Rittman the Company’s CTO.
There
is no guarantee that the Company will be successful in researching, developing
or implementing this testing, or in obtaining FDA certification. In order to successfully implement this
concept, the Company will need to raise adequate capital to support its research
and, if successfully researched, developed and granted regulatory approval, the
Company would need to enter into a strategic relationship with a third party
that has experience in manufacturing, selling and distributing this
product. There is no guarantee that the
Company will be successful in any or all of these critical steps.
About Us
GBT
Technologies, Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development stage company which
considers itself a native of Internet of Things (IoT), Artificial Intelligence
(AI) and Enabled Mobile Technology Platforms used to increase IC performance.
GBT has assembled a team with extensive technology expertise and is building an
intellectual property portfolio consisting of many patents. GBT’s mission, to
license the technology and IP to synergetic partners in the areas of hardware
and software. Once commercialized, it is GBT’s goal to have a suite of products
including smart microchips, AI, encryption, Blockchain, IC design, mobile
security applications, database management protocols, with tracking and
supporting cloud software (without the need for GPS). GBT envisions this system
as a creation of a global mesh network using advanced nodes and super performing
new generation IC technology. The core of the system will be its advanced
microchip technology; technology that can be installed in any mobile or fixed
device worldwide. GBT’s vision is to produce this system as a low cost, secure,
private-mesh-network between any and all enabled devices. Thus, providing
shared processing, advanced mobile database management and sharing while using
these enhanced mobile features as an alternative to traditional carrier
services.
Forward-Looking Statements
Certain
statements contained in this press release may constitute "forward-looking
statements". Forward-looking statements provide current expectations
of future events based on certain assumptions and include any statement that
does not directly relate to any historical or current fact. Actual results may
differ materially from those indicated by such forward-looking statements as a
result of various important factors as disclosed in our filings with the
Securities and Exchange Commission located at their website ( http://www.sec.gov). In addition to these
factors, actual future performance, outcomes, and results may differ materially
because of more general factors including (without limitation) general industry
and market conditions and growth rates, economic conditions, governmental and
public policy changes, the Company’s ability to raise capital on acceptable
terms, if at all, the Company’s successful development of its products and the
integration into its existing products and the commercial acceptance of the
Company’s products. The forward-looking statements included in this press
release represent the Company's views as of the date of this press release and
these views could change. However, while the Company may elect to update
these forward-looking statements at some point in the future, the Company
specifically disclaims any obligation to do so. These forward-looking
statements should not be relied upon as representing the Company's views as of
any date subsequent to the date of the press release.
Contact:
Dr.
Danny Rittman, CTO
press@gopherprotocol.com
GBT Technologies Inc.
(OTCQB:GTCH) is a featured tech stock on
More info on GTCH at
Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/
Get
News Alerts on GBT Technologies Inc GTCH
Disclaimer/Disclosure: Investorideas.com
is a digital publisher of third party sourced news, articles and equity
research as well as creates original content, including video, interviews and
articles. Original content created by investorideas is protected by copyright
laws other than syndication rights. Our site does not make recommendations for
purchases or sale of stocks, services or products. Nothing on our sites should
be construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Disclosure: GTCH is a PR, social media and publishing client and
compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp
Contact management and IR of each company directly regarding specific
questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn
more about publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/
and tickertagstocknews.com Global investors
must adhere to regulations of each country. Please read Investorideas.com
privacy policy: https://www.investorideas.com/About/Private_Policy.asp
Get more tech stocks investor ideas- news, articles, podcasts and stock directories
